Clinical Trial Update: Pharmacodynamic Evaluation of Antiplatelet Effect of Swallowing Versus Chewing Ticagrelor in Patients With Acute Coronary Syndrome [Phase 4]

View source ↗

Summary

Phase 4 trial evaluating pharmacodynamic effects of swallowing versus chewing ticagrelor in acute coronary syndrome patients.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Coronary Syndrome

Drugs mentioned

• TICAGRELOR (ticagrelor)

Snippet

Sponsor: Centro Hospitalario La Concepcion | Conditions: Acute Coronary Syndrome | Phase 4 | Status: UNKNOWN